The type 2 diabetes drug metformin helped slow aging across multiple organs, including the brain, kidneys, and the skin, a ...

Researchers in China examined middle-aged male monkeys and found that those given a daily dose of metformin over three years ...

The U.S. Food and Drug Administration lifted a clinical hold on Biomea Fusion's ongoing studies of its experimental drug for ...

The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

Metformin, a common medication used to treat type 2 diabetes, may also help reduce the viral reservoir in people living with ...

Television presenter James Corden claimed the controversial drug - traditionally used to treat type II diabetes - 'didn't ...

Biomea Fusion has escaped from the full clinical hold imposed by the FDA. | Biomea Fusion has escaped from the full clinical hold imposed by the FDA. After reviewing the data, the regulator has ...

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its ...

Researchers have identified a potential new approach to address the opioid overdose epidemic. Semaglutide was shown to lower opioid overdoses in people with opioid-use disorder and type 2 diabetes.

New research analyzing the effects of two drugs used to treat type 2 diabetes indicates a consistent lack of cardiovascular and renal benefits in Black populations.